Adams Looks To Mucinex Extensions; “Mr. Mucus” Marries

Adams Respiratory Therapeutics sees additions to its Mucinex extended-release guaifenesin line as "key" to the firm's long-term growth strategy

More from Archive

More from Pink Sheet